131 related articles for article (PubMed ID: 16997516)
1. Multivariate toxicity screening of liposomal formulations on a human buccal cell line.
Smistad G; Jacobsen J; Sande SA
Int J Pharm; 2007 Feb; 330(1-2):14-22. PubMed ID: 16997516
[TBL] [Abstract][Full Text] [Related]
2. Influence of liposomal formulation variables on the interaction with Candida albicans in biofilm; a multivariate approach.
Smistad G; Nguyen NB; Hegna IK; Sande SA
J Liposome Res; 2011 Mar; 21(1):9-16. PubMed ID: 20196625
[TBL] [Abstract][Full Text] [Related]
3. The influence of liposomal formulation factors on the interactions between liposomes and hydroxyapatite.
Nguyen S; Solheim L; Bye R; Rykke M; Hiorth M; Smistad G
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):354-61. PubMed ID: 20022224
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
[TBL] [Abstract][Full Text] [Related]
5. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
El-Samaligy MS; Afifi NN; Mahmoud EA
Int J Pharm; 2006 Feb; 308(1-2):140-8. PubMed ID: 16356669
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir.
Pavelić Z; Skalko-Basnet N; Filipović-Grcić J; Martinac A; Jalsenjak I
J Control Release; 2005 Aug; 106(1-2):34-43. PubMed ID: 15979189
[TBL] [Abstract][Full Text] [Related]
8. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy.
Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A
J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367
[TBL] [Abstract][Full Text] [Related]
9. Drug-liposome distribution phenomena studied by capillary electrophoresis-frontal analysis.
Ostergaard J; Jorgensen L; Engelbrecht Thomsen A; Weng Larsen S; Larsen C; Jensen H
Electrophoresis; 2008 Aug; 29(16):3320-4. PubMed ID: 18651665
[TBL] [Abstract][Full Text] [Related]
10. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents.
Rathore SS; Ghosh PC
Int J Pharm; 2008 Feb; 350(1-2):79-94. PubMed ID: 17913409
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-coated liposomes for delivery to lungs by nebulisation.
Zaru M; Manca ML; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
[TBL] [Abstract][Full Text] [Related]
12. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
Dabbas S; Kaushik RR; Dandamudi S; Kuesters GM; Campbell RB
Endothelium; 2008; 15(4):189-201. PubMed ID: 18663622
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of some charged lipids used in liposome preparations.
Campbell PI
Cytobios; 1983; 37(145):21-6. PubMed ID: 6851664
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin-liposome interactions: characterization of liposomal formulations of an acylated 28-amino acid peptide using CE.
Østergaard J; Moeller EH
Electrophoresis; 2010 Jan; 31(2):339-45. PubMed ID: 20024925
[TBL] [Abstract][Full Text] [Related]
15. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes.
Malaekeh-Nikouei B; Jaafari MR; Tabassi SA; Samiei A
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):238-44. PubMed ID: 18930640
[TBL] [Abstract][Full Text] [Related]
16. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines.
Matsingou C; Dimas K; Demetzos C
Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195
[TBL] [Abstract][Full Text] [Related]
17. The release and detection of endotoxin from liposomes.
Harmon P; Cabral-Lilly D; Reed RA; Maurio FP; Franklin JC; Janoff A
Anal Biochem; 1997 Aug; 250(2):139-46. PubMed ID: 9245430
[TBL] [Abstract][Full Text] [Related]
18. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
19. The use of phospholipid liposomes for targeting to oral and skin-associated bacteria.
Jones MN; Kaszuba M; Hill KJ; Song YH; Creeth JE
J Drug Target; 1994; 2(5):381-9. PubMed ID: 7704482
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic action of phospholipase A₂ on liposomal drug delivery systems.
Hansen AH; Mouritsen OG; Arouri A
Int J Pharm; 2015 Aug; 491(1-2):49-57. PubMed ID: 26056930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
